New Data Presented at ATS 2023 Reinforce Clinical Utility of

Veracyte, Inc. today announced new data suggesting its novel genomic tests may positively impact diagnosis and care for patients being evaluated for interstitial lung disease or lung cancer. The... | June 11, 2023

Related Keywords

Washington , United States , Massachusetts , Boston , University Of Washington Medical Center , American , Fayez Kheir , Ganesh Raghu , Twitter , Nasdaq , American Thoracic Society , Veracyte Inc , Envisia Genomic Classifier , Massachusetts General Hospital , Genomic Classifier , Interstitial Lung Diseases , Washington Medical , Percepta Nasal Swab , Bill Bulman , Annual Report , Quarterly Report ,